Publications by authors named "Fenfei Zou"

Claim this Profile
L
Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study.
Shinji Nakamichi, Kaoru Kubota, Fenfei Zou, Anna Hayashi, Natsuki Takano

Int J Clin Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancer.
Shinji Nakamichi, Masahiro Seike, Akihiko Miyanaga, Mika Chiba, Fenfei Zou

Oncotarget· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of NSCLC and Response to EGFR-TKIs of EGFR-Mutated NSCLC Based on PD-L1 Expression.
Kenichi Kobayashi, Masahiro Seike, Fenfei Zou, Rintaro Noro, Mika Chiba

Anticancer Res· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic significance of ABCB1 in stage I lung adenocarcinoma.
Fenfei Zou, Masahiro Seike, Rintaro Noro, Shinobu Kunugi, Kaoru Kubota

Oncol Lett· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AXL and GAS6 co-expression in lung adenocarcinoma as a prognostic classifier.
Masahiro Seike, Cheol-Hong Kim, Fenfei Zou, Rintaro Noro, Mika Chiba

Oncol Rep· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.
Teppei Sugano, Masahiro Seike, Rintaro Noro, Chie Soeno, Mika Chiba, Fenfei Zou

Mol Cancer Ther· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation.
Rintaro Noro, Masahiro Seike, Fenfei Zou, Chie Soeno, Kuniko Matsuda

BMC Cancer· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of osteopontin in the sensitivity of malignant pleural mesothelioma to pemetrexed.
Susumu Takeuchi, Masahiro Seike, Rintaro Noro, Chie Soeno, Teppei Sugano, Fenfei Zou

Int J Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis